BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qian HL, Peng XX, Chen SH, Ye HM, Qiu JH. p62 expression in primary carcinomas of the digestive system. World J Gastroenterol 2005; 11(12): 1788-1792 [PMID: 15793865 DOI: 10.3748/wjg.v11.i12.1788]
URL: https://www.wjgnet.com/1948-5182/full/v11/i12/1788.htm
Number Citing Articles
1
Shinichi Aishima, Nobuhiro Fujita, Yohei Mano, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Yoshinao Oda, Masazumi Tsuneyoshi. p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver DiseaseAmerican Journal of Clinical Pathology 2010; 134(3): 457 doi: 10.1309/AJCP53YVVJCNDZIR
2
Dan Sun, Xiaoting Li, Yingjian He, Wenhui Li, Ying Wang, Huan Wang, Shanshan Jiang, Yan Xin. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivoOncotarget 2016; 7(49): 81062 doi: 10.18632/oncotarget.13188
3
Yongwu Chen, Chongwei Wang, Hui Yang, Ping Huang, Jiana Shi, Yongxi Tong, Jinying Jiang, Xin Zhang, Wanyuan Chen, Zixue Xuan, Wei Lei. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from ChinaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8894498
4
Helmut Denk, Conny Stumptner, Peter M. Abuja, Kurt Zatloukal. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinomaExpert Opinion on Therapeutic Targets 2019; 23(5): 393 doi: 10.1080/14728222.2019.1601703
5
Francesca Mariotti, Gian Enrico Magi, Alessandra Gavazza, Silvia Vincenzetti, Andrey Komissarov, Alex Shneider, Franco Maria Venanzi. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notesVeterinary and Comparative Oncology 2019; 17(4): 570 doi: 10.1111/vco.12523
6
Chandra B. Lebovitz, Svetlana B. Bortnik, Sharon M. Gorski. Here, There Be Dragons: Charting Autophagy-Related Alterations in Human TumorsClinical Cancer Research 2012; 18(5): 1214 doi: 10.1158/1078-0432.CCR-11-2465
7
Euthymios Dimitriadis, Theoni Trangas, Stavros Milatos, Periklis G. Foukas, Ioannis Gioulbasanis, Nelly Courtis, Finn C. Nielsen, Nikos Pandis, Urania Dafni, Georgia Bardi, Panayotis Ioannidis. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancerInternational Journal of Cancer 2007; 121(3): 486 doi: 10.1002/ijc.22716
8
Stephan Laggai, Sonja M. Kessler, Stefan Boettcher, Valérie Lebrun, Katja Gemperlein, Eva Lederer, Isabelle A. Leclercq, Rolf Mueller, Rolf W. Hartmann, Johannes Haybaeck, Alexandra K. Kiemer. The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosisJournal of Lipid Research 2014; 55(6): 1087 doi: 10.1194/jlr.M045500
9
Amr Abdel-Moety, Nahed Baddour, Perihan Salem, Hesham El-Tobgy, Assem El-Shendidi. SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency AblationJournal of Clinical and Experimental Hepatology 2022; 12(3): 774 doi: 10.1016/j.jceh.2021.12.001
10
Pavel Strnad, Renwar Nuraldeen, Nurdan Guldiken, Daniel Hartmann, Vineet Mahajan, Helmut Denk, Johannes Haybaeck. Comprehensive Physiology2013; : 1393 doi: 10.1002/cphy.c120032
11
Shun Nakayama, Hideaki Karasawa, Takashi Suzuki, Shinichi Yabuuchi, Kiyoshi Takagi, Takashi Aizawa, Yoshiaki Onodera, Yasuhiro Nakamura, Mika Watanabe, Fumiyoshi Fujishima, Hiroshi Yoshida, Takanori Morikawa, Tomohiko Sase, Takeshi Naitoh, Michiaki Unno, Hironobu Sasano. p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferationCancer Medicine 2017; 6(6): 1264 doi: 10.1002/cam4.1093
12
Eun Mi Je, Nam Jin Yoo, Sug Hyung Lee. Alteration of p62/SQSTM1 Expression Is Uncommon in Gastrointestinal and Prostate Cancer TissuesGut and Liver 2013; 7(5): 625 doi: 10.5009/gnl.2013.7.5.625
13
Qiong Wu, Manlin Xiang, Kun Wang, Zhen Chen, Lu Long, Ya Tao, Yunlai Liang, Yahui Yan, Zhiqiang Xiao, Shiyang Qiu, Bin Yi. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling PathwayCurrent Cancer Drug Targets 2020; 20(8): 624 doi: 10.2174/1568009620666200424145122
14
Huimei Yu, Jing Su, Ye Xu, Jinsong Kang, Hongyan Li, Ling Zhang, Haowei Yi, Xiyan Xiang, Fei Liu, Liankun Sun. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteinsEuropean Journal of Cancer 2011; 47(10): 1585 doi: 10.1016/j.ejca.2011.01.019
15
Lifeng Feng, Yanning Ma, Jie Sun, Qi Shen, Leiming Liu, Haiqi Lu, Faliang Wang, Yongfang Yue, Jiaqiu Li, Shenjie Zhang, Xiaoying Lin, Jue Chu, Weidong Han, Xian Wang, Hongchuan Jin. YY1-MIR372-SQSTM1 regulatory axis in autophagyAutophagy 2014; 10(8): 1442 doi: 10.4161/auto.29486
16
Anish Babu, Qi Wang, Ranganayaki Muralidharan, Manish Shanker, Anupama Munshi, Rajagopal Ramesh. Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer CellsMolecular Pharmaceutics 2014; 11(8): 2720 doi: 10.1021/mp500259e
17
J Moscat, M T Diaz-Meco, M W Wooten. Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complexCell Death & Differentiation 2009; 16(11): 1426 doi: 10.1038/cdd.2009.119